ANALOGIFREMGANGSMAATE TIL FREMSTILLING AV NYE TERAPEUTISK VIRKSOMME 1,6-ANHYDRO-BETA-D-HEKSOPYRANOSEDERIVATER

摘要

The invention relates to novel 1,6-anhydro- beta -D-hexopyranose derivatives of the formula I <IMAGE> in which R2 is hydrogen, methyl or aromatic acyl, R3 and R4 are alkyl, alkenyl or aralkyl and one of the radicals R3 and R4 is also an aroyl radical and R4 can also be hydrogen, with the proviso that the radicals R3 and R4 together contain at least 3 carbon atoms and, if R4 is the benzyl radical, the radical R3 contains at least 2 carbon atoms, and, if one of the radicals R3 and R4 is an aroyl radical, R2 is hydrogen. These compounds especially the 1,6-anhydro-3,4-di-O-benzyl- beta -D-glucopyranose or the 1,6-anhydro- beta -D-glucopyranose, can be used as fibrinolytic agents and thrombolytic agents.